Agile Therapeutics
AGRX
$0.40
Share price
0.00%
Change (1 day)
-93.94%
Change (1 year)
Categories
Revenue for Agile Therapeutics (AGRX)
Revenue in 2023 (TTM): $19.59 M
According to Agile Therapeutics 's latest financial reports the company's current revenue (TTM) is $19.59 M. In 2022 the company made a revenue of $10.88 M an increase over the years 2021 revenue that were of $4.1 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Agile Therapeutics from 2013 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $19.59 M | 79.99% |
| 2022 | $10.88 M | 165.36% |
| 2021 | $4.1 M | 447.66% |
| 2020 | $0.74 M | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 474,695.84% | 🇺🇸 USA |
 Pfizer PFE | $58.49 B | 298,475.95% | 🇺🇸 USA |
 Merck MRK | $60.11 B | 306,729.32% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $1.95 M | -90.04% | 🇺🇸 USA |
 Antares Pharma ATRS | $0.18 B | 839.07% | 🇺🇸 USA |